Meir Panim implements programs that serve Israel’s neediest populations with respect and dignity. Meir Panim also coordinated care packages for families in the South during the Gaza War.
Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.
The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.
“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.
“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.
“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.
Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.
Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.
Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.
According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.
“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.
About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.
If you don't see your comment after publishing it, refresh the page.
Comments are closed.
Starting the 7th of Cheshvan in the Jewish calendar, Jews in Israel will start inserting the formal request for rain in the 9th blessing of the Amidah prayer.
Doctors are predicting minimal long-term disability to Yehudah Glick following surgery today.
Sweden and John Kerry would make wonderful partners to get lost in the same maze.
Pictured is an IDF ceremony for graduates of the “Little Heroes” foundation, which works to integrate kids with special needs in society, on October 30, 2014. The annual ceremony is in cooperation with the Logistics Corps in order to strengthen the connection between the IDF and the special needs community.
“It’s serious, there are now genuine questions being asked about whether we will be able to vote Labor next May.”
He is not in a coma and may undergo another operation today.
Israel’s anti-Netanyahu media might regret their wishes if early elections are held.
Authorities in Peru this week arrested a suspected Hezbollah terrorist who planned to murder Jews. Lebanese citizen Mohammed Hamden was in possession of explosives and other materials when he was arrested, according to the Peruvian Interior Ministry. Police found traces of TNT, detonators and other explosive devices in his apartment. Reports indicate that the suspect […]
Israel decides not to go ahead with huge military purchase from U.S., likely to provoke rumors of continuing feud.
What do you expect them to do on their Sabbath, pray?
Highlight: Exclusive Interview with Rabbi Yehuda Glick at the Foot of the Temple Mount.
Doctors reported as of 8 p.m. (2 p.m. EDT) Thursday night that there is a “very small” improvement in the condition of Yehuda Glick, gunned down by an Arab terrorists Wednesday night, but that he still is in critical condition and his life remains in danger.
Foreign Minister Lieberman may be playing “chicken.” What happens if France follows Sweden?
China has acquired $7 billion in Israeli assets in the past three years.
“For these international artists, the history and heroism at Masada together with performing at the lowest point on earth – 424 meters under the sea – is something that is truly unique,” Yossef explained.
Israelis of all ages watched in fascination as the Hawaiian-born Japanese-Samoan former sumo star, Konishiki Yasokichi shared his moves during a special workshop for children in Jerusalem.
An Israeli and an Arab poll results after the war.
In a sukkah on a hilltop outside Jerusalem, 20 international parliamentarians gathered together at the Psagot winery on Sunday evening, October 12 as part of a solidarity trip to Israel with the Israel Allies Caucuses.
3000 years ago, King David probably never imagined cars racing at 240 kilometers per hour through the ancient capital of the Jewish people.
Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/
Scan this QR code to visit this page online: